JNM Global

Global Approval Partner

JNM Global 312

Thailand TFDA, Announcement of Guidelines for Software as a Medical Device (SaMD) Registration

Thailand's Food and Drug Administration (TFDA) has issued guidelines on May 9, 2024 for registration of software (SaMD) to determine whether SaMD software is suitable as a medical device. The guidelines for Software as a Medical Device (SaMD) registration are briefly as follows.  Type of medical device software >-       Embedded Software: Software embedded in medical devices-       Standalone So..

Korea MFDS, Announcement of revised medical device Adverse Event report guidelines

On May 27, 2024, the Ministry of Food and Drug Safety (MFDS) posted a revised version of the "Medical Device Adverse Event Report Guidelines" reflecting the revision of the standard code for medical device abnormalities and the frequently used standard code case. The medical device safety information management system is briefly as follows.1. If the medical device handler recognizes that death o..

Singapore HSA, Issuing guidelines for submission of medical device registration documents for in vitro diagnostics

HAS Medical device product registration applications,  specifically for in vitro diagnostic devices, should be submitted online through MEDICS, utilizing the CSDT or IMDRF IVD MA ToC.In this regard, the Singapore HSA(Health Sciences Authority) issued a directive document on the submission of product registration on March 1, 2024.It details the process for uploading documents related to either th..

Indonesia MoH, Announcement of the Implementation of CDAKB(GOOD DISTRIBUTION PRACTICE REQUIREMENTS) Certificate as a Requirement for Marketing Authorization

On May 16, 2024, the Indonesia Ministry of Health issued an Announcement Number FR.03.01/E/884/2024 about the Implementation of the CDAKB Certificate (Good Distribution Practice of Medical Devices) as a Requirement for Marketing Authorization. The Ministry of Health (MoH) is providing a transition period from May 1st to June 30th, 2024. Therefore, Local Distributors and License Holders must have..

Philippines PFDA, FDA Circular No.2024-003_CMDN deadline extended to 2024 following amendments to An-nex A of FDA Circular No. 2020-001

Philippine FDA announced FDA Circular No.2024-003 on March 26, 2024. This issuance extended the dates for the application of a CMDN and CMDR for all Class B, C and D medical device that are not included in the list of registrable medical devices based on FC No. 2020-001-A. All Class B, C and D medical devices that are not included in the list of registrable medical devices based on FC No. 2020-0..

Canada Health Canada, Amending the Medical Devices Regulations (Medical Devices for an Urgent Public Health Need): SOR/2023-277)

On February 22, 2023, the Regulations Amending the Medical Devices Regulations (Interim Order No. 3 Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19) (the COVID-19 Medical Devices Regulations) came into force and created a permanent regulatory framework under Part 1.1 of the MDR for COVID-19 medical devices. Health Canada has expanded the scope of Part 1.1 f..

Mexico COFEPRIS, Announcement of Draft Revised Labeling Standards(NOM-137-SSA1-2024)

What is NOM (Norma Oficial Mexicana)? Mexico regulatory standards that manufacturers meet to protect the safety of medical device, IVD, and pharmaceutical users. Mexico COFEPRIS invalidated the standard NOM-137-SSA1-2008 on medical device labeling published in December 2008, and announced an updated new NOM for medical device labeling, NOM-137-SSA1-2024, on April 23, 2024. Updated NOM-137-SSA1-2..

China NMPA, Announcement of notice on improving cosmetics safety evaluation and management measures

NMPA announced “notice on improving cosmetics safety evaluation and management measures” on April 22, 2024 to further optimize cosmetics safety evaluation and management and to promote orderly implementation of the cosmetics safety evaluation system. This announcement will take effect from May 1, 2024. The contents of the notice, which will take effect from May 1, 2024, are as follows. 1. Classi..

JNM Global/Cosmetic 2024.04.29

MFDS, Publication of guidelines for evaluating physical and chemical properties of non-absorbable polymer materials for biological safety evaluation of medical devices

The Ministry of Food and Drug Safety published 「Guidelines for evaluating physical and chemical properties of non-absorbable polymer materials for biological safety evaluation of medical devices」 on April 08, 2024 to help prepare biological evaluation data for medical devices by explaining the requirements, evaluation principles, and processes of data on physical and chemical characteristics ana..

FDA, Select Updates for the Premarket Cybersecurity Guidance: Section 524B of the FD&C Act

The U.S. Food and Drug Administration published a draft guidance document on March 13, 2024, of Select Updates for the Premarket Cybersecurity Guidance: Section 524B of the FD&C Act. FDA intends to incorporate the updates proposed in this draft guidance into the Premarket Cybersecurity Guidance as one final guidance document after obtaining and considering public comment on these proposed select..